Safety and efficacy of transpupillary silicone oil removal in combination with micro-incision phacoemulsification cataract surgery: comparison with 23-gauge approach

Xu, Wei; Cheng, Weiqiang; Zhuang, Hua; Guo, Jiansheng; Xu, Guo

doi:10.1186/s12886-018-0878-z

Cited by 6 publications

(5 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Xu et al transpupillary removal vs. pars plana SO removal combined with standard phaco-cataract removal. The study found that early IOP was lower with transpupillary approach however this approach does not allow management of new posterior segment pathology found intraoperatively [47].…”

Section: Discussionmentioning

confidence: 83%

Silicone oil removal: post-operative complications

Issa

Xia

Zarbin

et al. 2019

Eye

View full text Add to dashboard Cite

Purpose To describe the characteristics, outcomes and complications of eyes after silicone oil removal. Methods Retrospective case series of eyes that underwent oil removal between 2012 and 2016 at The Institute of Ophthalmology and Visual Science. Visual acuity (VA), intraocular pressure (IOP) and rates of retinal re-detachment, hypotony, ocular hypertension, corneal decompensation, cystoid macular edema (CME) and cataract progression were evaluated. Results Totally, 101 eyes of 99 patients (65% male, average age 47.2 years) were identified. Oil tamponade had been used for retinal detachment (RD) repair in all eyes; 15 eyes had also undergone an open globe repair previously. The most common vitreous substitutes used after oil removal were balanced salt solution (BSS) and air in 90% of eyes. The average time of oil tamponade before removal was 9.46 months. The average logMAR VA before oil removal was 1.7 which improved to an average of 1.4 post-operatively. The average IOP pre-operatively was 16.1 mm Hg, which decreased to an average of 14.8 mm Hg post-operatively. Complications after oil removal, included retinal re-detachment (6.9%), hypotony (7.9%), ocular hypertension (12.9%), corneal decompensation (9.9%), CME (2%) and cataract progression (68%). Conclusion This study showed an overall improvement in VA and decrease in IOP after oil removal. Cataract progression was the most common complication.

show abstract

Section: Discussionmentioning

confidence: 83%

Silicone oil removal: post-operative complications

Issa

Xia

Zarbin

et al. 2019

Eye

View full text Add to dashboard Cite

show abstract

“…o No recurrent retinal detachment. It is difficult to unequivocally comment on more than 15% of recurrent retinal detachment, described by Xu et al after oil removal via the anterior chamber [6]. Such a large difference, i.e., the lack of recurrent retinal detachment in the described group, may be due to the fact that all procedures were performed by one surgeon, including qualification for silicone oil removal, or the use of passive oil removal technique, not active aspiration as described by Xu.…”

Section: B Postoperative Complicationsmentioning

confidence: 84%

“…o Significant reduction of the procedure duration. So, removal via a 2-2.5 mm incision is much more effective than via a pars plana 0.9-0.5 mm incision, even when using the active aspiration technique [6].…”

Section: B Postoperative Complicationsmentioning

confidence: 99%

See 1 more Smart Citation

Removal of Silicon Oil from the Vitreous Cavity via the Anterior Chamber. Eight Years of the Author’s Experiences

Cywinski¹

2021

EJMED

View full text Add to dashboard Cite

Purpose: To evaluate usefulness and safety of removal of silicone oil from the vitreous cavity via the anterior chamber. Methods: The procedures were performed between 2012 and 2020 in 31 patients who required endotamponade with the use of light silicone oils. In most of the patients, the procedure was combined with cataract removal, secondary lens implantation or transscleral fixation of an artificial lens. A passive bimanual technique was used to replace silicone oil with fluid. Results: The procedure to remove silicon oil via the anterior chamber proceeded without serious intra- and postoperative complications. There were no hypotony observed in first postoperative day. Conclusion: Patients eligible for the procedure are those who have preoperative indications for silicone oil removal and whose removal path via the anterior chamber is not associated with a special need to remove the lens from the eye.

show abstract

“…However, one of commonly used and feasible method is the removal of silicone oil (ROSO) as soon as the retina stabilizes. 6 Unfortunately, in many cases, silicone oil may not be removed for a while and consequently develop a posterior cataract. Thus, oil and cataract extraction surgery is the only method to restore the vision of the patient.…”

Section: Introductionmentioning

confidence: 99%

Comparison of visual acuity and post-operative inflammation in phacoemulsification and removal of silicone oil with and without injection of Enoxaparin Sodium (40mg/0.04ml)

Buksh¹,

Khaqan²,

Imtiaz³

et al. 2021

J Fatima Jinnah Med Univ

View full text Add to dashboard Cite

Background: Phacoemulsification and removal of silicone oil (ROSO) is a combined, frequently done procedure in retina theatre. A common problem in this procedure is the post inflammation that affects the recovery of the patients. Thus to counter this post-operative inflammation, the study has used Enoxaparin Sodium (an anti-inflammatory enoxaparin) to counter the post-operative inflammation in phacoemulsification and ROSO. Patients and methods: Prospective interventional study done at Ophthalmology Department, Lahore General Hospital, included 60 patients which were operated and observed for results over a period of 3 months. Total 60 patients were randomly allocated in two groups, Group A and B. Both groups underwent phacoemulsification and ROSO. Group A had Enoxaparin Sodium, admixed in infusion bottles with a dosage of 40mg/0.04ml while Group B was operated without Enoxaparin Sodium. Patients were examined on slit lamp on the 1st day after the surgery then on the 7th day and every month for 3 months for post-operative inflammation and visual recovery. The effectiveness of the procedure was defined by the comparison of post-operative inflammation as well as speedy recovery of sight. Results: Total 60 patients were randomly allocated in two groups. Group A had 30 patients, 23 males and 7 females, with mean age of 49.43 years. Group B included 30 patients, 19 males and 11 females, with mean age of 47.73 years. Post-operative BCVA in Group A was above vision 6/60 (Snellen’s Chart) in 90% of cases while it improved to vision 6/36 and better in 93% of cases at 7th day while 93% of cases crossed recovery of Vision 6/18 by 3rd Month. While in Group B, Vision 6/60 was observed in 70% of cases while it improved to vision 6/36 and better in 67% of cases at 7th day while 53% of cases crossed recovery of vision 6/18 by 3rd Month. Post-operative results for inflammation of Group B showed grade 3 reaction on first day (94%) while it reduced to grade 2 reaction on 7th day in 97% of the cases. While Group A was observed with occasional activity in 25 out of 30 cases (84%) on the first day and grade 2 reaction in 5 (16%) cases. 100% cases of Group A showed occasional activity on 7th day with better visual recovery. Conclusion: Intraoperative use of Enoxaparin Sodium helped in reducing post-operative inflammation as well as aided in better visual acuity after phacoemulsification and ROSO thus proving to be a viable enoxaparin agent to reduce post-operative reactions in these surgeries.

show abstract

Safety and efficacy of transpupillary silicone oil removal in combination with micro-incision phacoemulsification cataract surgery: comparison with 23-gauge approach

Cited by 6 publications

References 16 publications

Silicone oil removal: post-operative complications

Silicone oil removal: post-operative complications

Removal of Silicon Oil from the Vitreous Cavity via the Anterior Chamber. Eight Years of the Author’s Experiences

Comparison of visual acuity and post-operative inflammation in phacoemulsification and removal of silicone oil with and without injection of Enoxaparin Sodium (40mg/0.04ml)

Contact Info

Product

Resources

About